GlaxoSmithKline’s (GSK) “Buy” Rating Reaffirmed at The Goldman Sachs Group
#glaxosmithkline
#gsk
#buy
3 years ago By Gomez — The Goldman Sachs Group restated their buy rating on shares of GlaxoSmithKline (LON:GSK) in a research note released on Thursday morning, Price Targets.com